| Resurfacing vs. THR by Mr. Mark Bloomfield, Orthopaedic Surgeon UK |
|
|
|
|
November 15, 2008
So DO NOT assume THR is problem free. One of the worst effects of THR, and one that we are lucky to so consistently get away with, is the invasion of the marrow of the femur [thigh bone] when the stem is placed deep into it. This generates enormous pressure which forces large fat globules/marrow contents into the bloodstream. The fat globules are filtered by the lungs, but can cause a subtle alteration or activation of the coagulation and immune systems that makes patients equally subtly feel and look unwell. You cannot scientifically -or at this stage I can't - put a finger on it, but this effect is avoided or greatly minimised in [Birmingham] hip resurfacing (BHR). The latter seem to 'bounce back' from surgery quicker than comparable THR patients. Designing and executing a study to prove this would be extremely complex so as to avoid bias, achieve case matching etc. And it would require large numbers of patients in each group. Lastly it would seem unethical to randomise patients to receive either a BHR or THR just to prove my point. So it is a study that may never be done. But the evidence re intra-op embolisation is intuitively relevant. Sadly, elderly patients who have emergency surgery for neck of femur fracture that consists of a hemi or total hip replacement not infrequently die in theatre shortly after the stem was inserted. This by the way, does not happen if the fracture is extra-capsular and therefore treatable by placing a screw or pin in the broken hip. |
| < Prev | Next > |
|---|





